Vaccination with streptococcal extracellular cysteine protease (interleukin-1β convertase) protects mice against challenge with heterologous group A streptococci
about
Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence.Viable group A streptococci in macrophages during acute soft tissue infectionStrategies in the development of vaccines to prevent infections with group A streptococcusPathogenesis of group A streptococcal infectionsGenetic inactivation of an extracellular cysteine protease (SpeB) expressed by Streptococcus pyogenes decreases resistance to phagocytosis and dissemination to organsEffect of group A streptococcal cysteine protease on invasion of epithelial cells.Role of streptococcal pyrogenic exotoxin B in the mouse model of group A streptococcal infection.A role for trigger factor and an rgg-like regulator in the transcription, secretion and processing of the cysteine proteinase of Streptococcus pyogenes.Fibrinogen cleavage by the Streptococcus pyogenes extracellular cysteine protease and generation of antibodies that inhibit enzyme proteolytic activity.Group A Streptococcus induces apoptosis in human epithelial cells.Absence of SpeB production in virulent large capsular forms of group A streptococcal strain 64Replacement of histidine 340 with alanine inactivates the group A Streptococcus extracellular cysteine protease virulence factorInverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection casesProgress in the development of effective vaccines to prevent selected gram-positive bacterial infections.Group A Streptococcus: allelic variation, population genetics, and host-pathogen interactions.Active and passive intranasal immunizations with streptococcal surface protein C5a peptidase prevent infection of murine nasal mucosa-associated lymphoid tissue, a functional homologue of human tonsils.Cysteine proteinase SpeB from Streptococcus pyogenes - a potent modifier of immunologically important host and bacterial proteins.Disease manifestations and pathogenic mechanisms of Group A Streptococcus.Proteolysis and its regulation at the surface of Streptococcus pyogenes.Characterization of an extracellular virulence factor made by group A Streptococcus with homology to the Listeria monocytogenes internalin family of proteins.Prophage induction and expression of prophage-encoded virulence factors in group A Streptococcus serotype M3 strain MGAS315.Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive diseaseStreptococcal cysteine protease augments lung injury induced by products of group A streptococci.Activation of a 66-kilodalton human endothelial cell matrix metalloprotease by Streptococcus pyogenes extracellular cysteine protease.Serotype M3 and M28 Group A Streptococci Have Distinct Capacities to Evade Neutrophil and TNF-α Responses and to Invade Soft Tissues.Active and passive immunizations with the streptococcal esterase Sse protect mice against subcutaneous infection with group A streptococciProspects for a group A streptococcal vaccine: rationale, feasibility, and obstacles--report of a National Institute of Allergy and Infectious Diseases workshop.Multilocus analysis of extracellular putative virulence proteins made by group A Streptococcus: population genetics, human serologic response, and gene transcription.Immunization with a streptococcal multiple-epitope recombinant protein protects mice against invasive group A streptococcal infectionStructural and functional analysis of RopB: a major virulence regulator in Streptococcus pyogenes.Vaccine based on a ubiquitous cysteinyl protease and streptococcal pyrogenic exotoxin A protects against Streptococcus pyogenes sepsis and toxic shock.Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains.Cutting edge issues in rheumatic fever.Vaccination against rheumatic heart disease: a review of current research strategies and challenges.The transcriptional regulator RovS controls the attachment of Streptococcus agalactiae to human epithelial cells and the expression of virulence genes.Streptococcal toxins: role in pathogenesis and disease.New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population.Extracellular cysteine protease produced by Streptococcus pyogenes participates in the pathogenesis of invasive skin infection and dissemination in mice.Characterization of the domain of fibronectin-binding protein I of Streptococcus pyogenes responsible for elicitation of a protective immune response.Expression and characterization of group A Streptococcus extracellular cysteine protease recombinant mutant proteins and documentation of seroconversion during human invasive disease episodes
P2860
Q22066234-A4D769B0-2C91-4094-A2D0-366A33FB3CEDQ25257256-4FF0833A-1B0F-433E-9A8F-D63B7ECE4760Q26863366-68CB1E49-B993-484C-8A21-F5DDAE410B9FQ29615547-DB176EB6-0280-4ABB-AEF3-7C4F2CC7AA2CQ33750595-8C19BEA8-A2C2-4E58-8043-9DAB4A5045EAQ33752246-AA8C2E9C-FBD4-4325-ACE8-411D0C678CC1Q33759303-04A4453A-9643-4A7D-B587-A401E6538A1BQ33889824-F0CA2F66-2E76-4528-9A1B-48FADD398927Q34001611-3B87DD66-0ABA-4701-9947-0382C1EB977AQ34001617-27C6EB0C-F421-43B4-B8D7-DB3B2B7B8FCDQ34003284-DC0DF94F-DF62-4449-B29F-7D553ECC4D0FQ34004857-40301CBE-F237-4EA7-BF09-45AD9E9B961FQ34005015-8078AB12-5288-4720-B9C7-89D0C0DFA959Q34112608-7CBAF383-B493-4C0D-8BF1-8A007BD4B321Q34142091-1BEAD24B-D73C-40F4-BA39-E462629632C1Q34194488-0E574CCC-4B49-49FF-8C76-52235E68DB0EQ34229809-33FDBA18-EB8C-4EB2-A623-EFF902807D3CQ34413457-543D82E3-9E3B-4607-BD6B-07AEE3895D9BQ34585533-99081C25-9299-4A5C-A4DC-D37ED1706655Q34942251-32011E00-9848-4FAF-A3D1-D912AB6D43AAQ34943643-A0E3A721-55DD-4603-B4B2-86BB701BB077Q35393989-2BAD48BC-55B6-415A-A94C-6277DB6A4CEDQ35474233-6B55AEB8-1DF9-4B16-BD86-532F4A110646Q35529708-B618109F-608F-4B3F-97EE-CC0AF964ABB9Q35654539-24FE4203-31EA-4490-998B-9715C60380B9Q35913574-71FCE4C1-595A-4C39-9867-8B709D6B88D5Q36257688-DBB97CFC-005C-4B0E-B4A1-099A1A038000Q36315066-D9588B9E-ED3A-49BC-A546-D7142F421999Q36326757-3308C904-244C-4555-8ADE-9838EE78EF9DQ36694367-6F718C87-7286-431A-A663-70BACE19180FQ36977951-9F355D83-101F-48CF-9E2D-E4C08FF2D002Q37367914-DB2F97DB-4912-4940-91B2-ECF1431546D2Q37877594-FBADAC9D-54EC-483B-808D-E02A95060518Q38021366-33619A31-5197-46DE-99FE-9E2CDC7B2DCAQ38484114-3E09F620-B7B2-4CD3-A975-B52BCE95E102Q38598360-2FBBB5B8-157A-4504-9206-BE6029FDACE7Q38919770-0A93BF05-5ABE-43CA-8D6A-8B05BBD9EFADQ39510467-86FD2AF9-CF26-4190-94FC-19D194BC540CQ39518108-E5282042-A311-4192-8DA6-3EBAAF139538Q39570060-48F1B56E-129F-4AD1-BADA-580B656904C1
P2860
Vaccination with streptococcal extracellular cysteine protease (interleukin-1β convertase) protects mice against challenge with heterologous group A streptococci
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована в червні 1994
@uk
name
Vaccination with streptococcal ...... erologous group A streptococci
@en
Vaccination with streptococcal extracellular cysteine protease
@nl
type
label
Vaccination with streptococcal ...... erologous group A streptococci
@en
Vaccination with streptococcal extracellular cysteine protease
@nl
prefLabel
Vaccination with streptococcal ...... erologous group A streptococci
@en
Vaccination with streptococcal extracellular cysteine protease
@nl
P2093
P356
P1476
Vaccination with streptococcal ...... erologous group A streptococci
@en
P2093
Gerald J. Adams
Joanne T. Maffei
Ling-Ling Li
Rebecca S. Greer
P304
P356
10.1006/MPAT.1994.1044
P577
1994-06-01T00:00:00Z